ReviewCancer2017
A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment.
Review in Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03780491 (Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care), which is not on this map. Cited by 78 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care
Who cites it
78 citing papers in PubMed, 3 syntheses or guidelines pooled it, 142 citations in OpenAlex.
- Communication of costs and financial burdens between cancer patients and healthcare providers: a qualitative systematic review and meta-synthesis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023Pooled it
- Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines.BMC cancer · 2021Pooled it
- Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes.Journal of the National Comprehensive Cancer Network : JNCCN · 2019Pooled it
- Not all cost conversations are the same: An exploration of potential value in cost conversations during Atrial fibrillation treatment decision making.Patient education and counseling · 2024Trial
- Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39).Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023Trial
- Trial
- Assessment of Financial Toxicity Among Older Adults With Advanced Cancer.JAMA network open · 2020Trial
- Advanced cancer treatment decisions and their patient-facing financial burdens: a thematic analysis.The oncologist · 2026Article
- Communication of Cost in Thyroidectomy: A Mixed-Methods Analysis of Financial Toxicity.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026Article
- Financial Toxicity in Patients With Breast Cancer Treated at Private Medicine Institutions in Brazil.Cancer medicine · 2026Article
- Financial Outlook thRough CAncer STorytelling (FOReCAST): Development of a Novel Video-Based Storytelling Intervention to Mitigate Financial Hardship Among Young Women with Breast Cancer.Annals of surgical oncology · 2026Article
- Measuring What Matters: Patient-Reported Outcomes in Colon Cancer Care.Clinics in colon and rectal surgery · 2025Review
- Article
- Understanding cancer survivor cost communication experiences and preferences.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- Experiences and coping strategies related to financial toxicity among frail older colorectal cancer survivors in China: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- Determining health care cost drivers in older Hodgkin lymphoma survivors using interpretable machine learning methods.Journal of managed care & specialty pharmacy · 2025Article
- Financial hardship, financial toxicity, and transportation challenges among older cancer survivors treated with curative-intent surgery.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2025Article
- Patient-Provider Cost-of-Care Conversations to Prevent Financial Toxicity.Clinical journal of oncology nursing · 2025Article
- National Survey of Factors Associated with Physician Antibiotic Prescribing Preferences.Journal of general internal medicine · 2025Article
18 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
Abstract
The American Society of Clinical Oncology released its first guidance statement on the cost of cancer care in August 2009, affirming that patient-physician cost communication is a critical component of high-quality care. This forward-thinking recommendation has grown increasingly important in oncology practice today as the high costs of cancer care impose tremendous financial burden to patients, their families, and the health care system. For the current review, a literature search was conducted using the PubMed and Web of Science databases to identify articles that covered 3 topics related to patient-physician cost communication: patient attitude, physician acceptance, and the associated outcomes; and 15 articles from 12 distinct studies were identified. Although most articles that addressed patient attitude suggested that cost communication is desired by >50% of patients in the respective study cohorts, only <33% of patients in those studies had actually discussed costs with their physicians. The literature on physician acceptance indicated that, although 75% of physicians considered discussions of out-of-pocket costs with patients their responsibility, <30% felt comfortable with such communication. When asked about whether cost communication actually took place in their practice, percentages reported by physicians varied widely from <10% to >60%. The data suggested that cost communication was associated with improved patient satisfaction, lower out-of-pocket expenses, and a higher likelihood of medication nonadherence; none of the studies established causality. Both patients and physicians expressed a strong need for accurate, accessible, and transparent information about the cost of cancer care. Cancer 2017;123:928-39. © 2016 American Cancer Society.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.